In vitro cytotoxic activities of (+)-usnic acid and (-)-usnic acid on V79, A549, and human lymphocyte cells and their non-genotoxicity on human lymphocytes

Natural Product Research

Volumn 20, Issue 14, 2006, Pages 1300-1307

  Koparal, A T ^a   Tüylü, B Ayaz ^a   Turk H ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

Cladonia foliacea; Cytotoxicity; Genotoxicity; Ramalina farinacea; Usnic acid

Indexed keywords

MITOMYCIN C; NATURAL PRODUCT; USNIC ACID; ANTINEOPLASTIC AGENT; BENZOFURAN DERIVATIVE; FORMAZAN; MTT FORMAZAN; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL KILLING; CELL PROLIFERATION; CLADONIA FOLIACEA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINESIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG ISOLATION; DRUG STRUCTURE; ENANTIOMER; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LICHEN; LYMPHOCYTE CULTURE; MICRONUCLEUS TEST; NONHUMAN; RAMALINA FARINACEA; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; FIBROBLAST; HAMSTER; LICHENS; LYMPHOCYTE; MALE; MUTAGEN TESTING; STEREOISOMERISM; TUMOR CELL LINE;

CLADONIA FOLIACEA; CRICETULUS GRISEUS; RAMALINA FARINACEA;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOFURANS; CELL LINE; CELL LINE, TUMOR; CRICETINAE; FIBROBLASTS; FORMAZANS; HUMANS; LICHENS; LYMPHOCYTES; MALE; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; STEREOISOMERISM; TETRAZOLIUM SALTS;

EID: 34247617727     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410601101910     Document Type: Article

References (24)

1. Huneck, S. (1999) Naturwissenschaften, 86, p. 559.
2. Cocchietto, M., Skert, N., Nimis, PL and Sava, G. (2002) Naturwissenschaften, 89, p. 137.
3. Ingólfsdóttir, K. (2002) Phytochemistry, 61, p. 729.
4. Periera, EC, Nascimento, SC, Lima, RC, Silva, NH, Oliveira, AF, Bandeira, E., Boitard, M., Beriel, H., Vicente, C. and Legaz, ME (1994) Tokai J. Exp. Clin. Med., 19, p. 47.
5. Kumar, KC and Muller, K. (1999) J. Nat. Prod., 62, p. 821.
6. Fournet, A., Ferreira, ME, de Arias, AR, de Ortiz, ST, Inchausti, A., Yaluff, G., Quilhot, W., Fernandez, E. and Hidalgo, ME (1997) Comp. Biochem. Physiol. Pharmacol. Toxicol. Endocrinol., 116, p. 51.
7. Krishna, DR and Venkataramana, D. (1992) Drug Metab. Dispos., 20, p. 909.
8. Ghione, M., Parrello, D. and Grasso, L. (1988) Chemioterapia, 7, p. 302.
9. Abo-Khatwa, AN, Al-Robai, AA and Al-Jawhari, DA (1996) Nat. Toxins, 4, p. 96.
10. Al-Bekairi, AM, Qureshi, S., Chaudhry, MA, Krishna, DR and Shah, AH (1991) J. Ethnopharmacol., 33, p. 217.
11. Tay, T., Turk, A.O.̈, Yilmaz, M., Türk, H. and Kivanç M. (2004) Z Naturforsch., 59, p. 384.
12. Yilmaz, M., Turk, AÖ, Tay, T., and Kivanç, M. (2004) Z Naturforsch., 59, p. 249.
13. Mossmann, T. (1983) J. Immunol. Methods, 65, p. 55.
14. Hoist, CM and Oredsson, SM (2005) Toxicol. In vitro, 19, p. 379.
15. Rothfuß, A., Schütz, P., Bochum, S., Volm, T., Eberthard, R., Kreirenberg, R., Vogel, W. and Speit, G. (2000) Cancer Res, 60, p. 390.
16. Lukinius, A., Bergström, M., Eriksson, B., Watanabe, Y. and Langström, B. (1999) Eur. J. Cancer, 35:7, p. 1155.
17. Han, D., Matsumaru, K., Rettori, D. and Kaplowitz, N. (2004) Biochem. Pharmacol., 67, p. 439.
18. Cardarelli, M., Serino, G., Campanella, L., Ercole, P., De Cicco, FN, Alesiani, O. and Rossiello, F. (1997) Cell. Mol. Life Sci., 53, p. 667.
19. Bézivin, C., Tomasi, S., Dévéhat, F Lohézic-Le and Boustie, J. (2003) Phytomedicine, 10, p. 499.
20. Bézivin, C., Tomasi, S., Rouaud, I., Delcros, JG and Boustie, J. (2004) Planta Med., 70:9, p. 874.
21. Shibamato, T. and Wei, CI (1984) Environ. Mutagen., 6, p. 757.
22. Fimognari, C., Nüsse, M., Cesari, R., Cantelli-Forti, G. and Hrelia, P. (2001) Mutat. Res., 495, p. 1.
23. Wolvetang, EJ, Jhonson, KL, Krauer, K., Ralph, SJ and Linnane, AW (1994) FEBS Lett., 339, p. 40.
24. Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, A. and Robinson, JP (2003) J. Biol. Chem., 278, p. 8516.